Health-care drama has now spread to biopharma stocks [MarketWatch]
Regeneron Pharmaceuticals, Inc. (REGN)
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.regeneron.com
Company Research
Source: MarketWatch
Health-care drama has now spread to biopharma stocks Health stocks had another bad day, with investor jitters spreading to the biotech and pharmaceutical sectors, as well. Investors’ anxiety seemed to have expanded from health retailers, managed care companies and health insurers to include biopharma companies on Thursday. The three biggest losers in the Health Care Select Sector SPDR Fund ETF XLV, +0.16% were Regeneron Pharmaceuticals Inc. REGN, -2.81% , Incyte Corp. INCY, -0.48% and Amgen Inc. AMGN, -2.74% The health-care ETF slid another 0.2% after falling 3% on Wednesday. It is now down 1% for the year, while the S&P 500 SPX, +0.16% has notched gains of around 16%. Pfizer Inc. PFE, -1.25% , Johnson & Johnson JNJ, -0.72% , Merck & Co. Inc. MRK, -0.99% and Walgreens Boots Alliance Inc. WBA, -0.92% were among the Dow Jones Industrial Average’s DJIA, +0.42% top five losers. The recent decline in health-care stocks comes during an uncertain time for the f
Show less
Read more
Impact Snapshot
Event Time:
REGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
REGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
News
- Toddler born deaf can hear after gene therapy trial breakthrough her parents call "mind-blowing" [CBS News]CBS News
- Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock continues to impress, up 3.2% over the past week [Yahoo! Finance]Yahoo! Finance
- Deaf Toddler Hears For The First Time After Pioneering Gene Therapy [Forbes]Forbes
- A deaf toddler can hear thanks to a world-first gene treatment that took just 16 minutes [Business Insider]Business Insider
- Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks [Yahoo! Finance]Yahoo! Finance
REGN
Earnings
- 5/2/24 - Beat
REGN
Sec Filings
- 5/6/24 - Form 4
- 5/3/24 - Form 4
- 5/3/24 - Form 4
- REGN's page on the SEC website